KRAS and neoplasm: PDAC tumor samples from the TCGA cohort were grouped as KRAS-dependent/KRAS type or KRAS-independent/RSK type based on previously derived KRAS dependency signatures (Figure 4—source data 3; Singh et al., 2009; Yuan et al., 2018).